• Consensus Rating: N/A
  • Consensus Price Target: GBX 0
  • Forecasted Upside: -100.00 %
  • Number of Analysts: 0
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
GBX 96.40
+0 (0.00%)

This chart shows the closing price for MXF by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Medicx Fund Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for MXF and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for MXF

Analyst Price Target is GBX 0
▼ -100.00% Downside Potential
This price target is based on 0 analysts offering 12 month price targets for Medicx Fund in the last 3 months. The average price target is GBX 0, with a high forecast of GBX 0 and a low forecast of £100,000. The average price target represents a -100.00% upside from the last price of GBX 96.40.

This chart shows the closing price for MXF for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is N/A

The current consensus among 0 investment analysts is to n/a stock in Medicx Fund. This N/A consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
6/17/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
9/15/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
12/14/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
3/14/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
6/12/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
9/10/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
11/9/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
12/9/2022

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
1/9/2019Liberum CapitalReiterated RatingBuy
12/17/2018Liberum CapitalReiterated RatingBuy
12/11/2018Peel HuntUpgradeHoldGBX 72 ➝ GBX 76
12/11/2018Liberum CapitalReiterated RatingBuyGBX 90
12/5/2018Liberum CapitalReiterated RatingBuy
10/19/2018Liberum CapitalReiterated RatingBuy
9/12/2018Liberum CapitalReiterated RatingBuy
7/23/2018Peel HuntReiterated RatingReduce
7/20/2018Liberum CapitalReiterated RatingBuy
7/6/2018Liberum CapitalInitiated CoverageBuyGBX 90
5/22/2018Peel HuntDowngradeReduceGBX 78 ➝ GBX 72
4/5/2018Peel HuntReiterated RatingHold
(Data available from 12/10/2017 forward)

News Sentiment Rating

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
5/14/2022
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
6/13/2022
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
7/13/2022
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
8/12/2022
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
9/11/2022
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
10/11/2022
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
11/10/2022
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
12/10/2022

Current Sentiment

  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

  • No positive mentions tracked during this time.

Very Positive

  • No very positive mentions tracked during this time.
Medicx Fund logo
MedicX Fund Limited ("MXF", "MedicX Fund", the "Fund" or the "Company", or together with its subsidiaries, the "Group") is the specialist primary care infrastructure investor in modern, purpose-built primary healthcare properties in the United Kingdom and Ireland, listed on the London Stock Exchange, with a portfolio comprising 154 properties. The Investment Adviser to the Company is Octopus Healthcare Adviser Ltd, which is part of the Octopus Healthcare group. Octopus Healthcare invests in and develops properties as well as creating partnerships to deliver innovative healthcare buildings to improve the health, wealth and wellbeing of the UK. It currently manages over £1.4 billion of healthcare investments across a number of platforms, with a focus on five core areas: GP surgeries, care homes, special education schools, retirement housing and private hospitals. Octopus Healthcare is part of the Octopus group, a fast-growing UK fund management business with leading positions in several specialist sectors including healthcare property, energy, property finance and smaller company investing. Octopus manages £7.7 billion of funds for more than 50,000 retail and institutional investors as well as supplying energy to more than 180,000 customers. Octopus Healthcare Adviser Ltd is authorised and regulated by the Financial Conduct Authority. The Company's website address is www.medicxfund.com. Neither the contents of the Company's website nor the contents of any website accessible from hyperlinks on the Company's website (or any other website), nor the contents of any website accessible from hyperlinks within this announcement, are incorporated into, or forms part of, this announcement. The Company's Legal Entity Identifier is 2138008POF35FTNFCB25.
Read More

Today's Range

Now: GBX 96.40
Low: 96.40
High: 96.40

50 Day Range

MA: GBX 96.40
Low: 96.40
High: 96.40

52 Week Range

Now: GBX 96.40
Low: 72.80
High: 97

Volume

8,763,813 shs

Average Volume

1,749,135 shs

Market Capitalization

N/A

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of Medicx Fund?

The following Wall Street analysts have issued stock ratings on Medicx Fund in the last year:
View the latest analyst ratings for MXF.

What is the current price target for Medicx Fund?

0 Wall Street analysts have set twelve-month price targets for Medicx Fund in the last year. has the lowest price target set, forecasting a price of £100,000 for Medicx Fund in the next year.
View the latest price targets for MXF.

What is the current consensus analyst rating for Medicx Fund?

Medicx Fund currently has from Wall Street analysts. The stock has a consensus analyst rating of "N/A."
View the latest ratings for MXF.

What other companies compete with Medicx Fund?

How do I contact Medicx Fund's investor relations team?

Medicx Fund's physical mailing address is Regency Court, Glategny Esplanade, ST PETER PORT, GY1 1WW, Guernsey. The company's listed phone number is +44-1481-723450. The official website for Medicx Fund is www.medicxfund.com. Learn More about contacing Medicx Fund investor relations.